tiprankstipranks
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market

Y-Mabs Therapeutics (YMAB) Similar Stocks

Compare
519 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Y-Mabs Therapeutics
$6.42
$277.69M
-61.02%
6 Buy
1 Hold
1 Sell
Moderate Buy
Nektar Therapeutics
$1.00
$195.53M
44.93%
4 Buy
0 Hold
0 Sell
Strong Buy
Bluebird Bio
$7.25
$69.22M
-66.74%
1 Buy
2 Hold
0 Sell
Moderate Buy
Fate Therapeutics
$1.71
$174.26M
-74.96%
3 Buy
2 Hold
0 Sell
Moderate Buy
Adaptimmune Therapeutics
$0.58
$149.00M
-61.47%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
YMAB
Y-Mabs Therapeutics
6.42
-10.05
-61.02%
NKTR
Nektar Therapeutics
1.00
0.31
44.93%
BLUE
Bluebird Bio
7.25
-14.55
-66.74%
FATE
Fate Therapeutics
1.71
-5.12
-74.96%
ADAP
Adaptimmune Therapeutics
0.58
-0.92
-61.33%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis